679 results on '"TIRODE, Franck"'
Search Results
2. S100 protein expression in PKC-fused blue naevi, cellular blue naevi and PRKAR1A-inactivated pigmented epithelioid melanocytomas
3. PEComa With MITF Overexpression: Clinicopathologic and Molecular Analysis of a Series of 36 Cases
4. Wnt/β-Catenin–Activated Nonpilomatrical Carcinoma of the Skin: A Case Series
5. Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights
6. MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation
7. SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors
8. A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas
9. Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes
10. Histologic and Genetic Features of 51 Melanocytic Neoplasms With Protein Kinase C Fusion Genes
11. GRM1 Gene Fusions as an Alternative Molecular Driver in Blue Nevi and Related Melanomas
12. Spectrum of Melanocytic Tumors Harboring BRAF Gene Fusions: 58 Cases With Histomorphologic and Genetic Correlations
13. Melanotic PEComa: A Rare But Distinctive Subtype Analyzed in a Series of 7 Cases
14. Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding
15. VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis
16. Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey
17. Brief Communication on MAGE-A4 and Coexpression of Cancer Testis Antigens in Metastatic Synovial Sarcomas: Considerations for Development of Immunotherapeutics.
18. Exploring the molecular landscape of cutaneous mixed tumors characterized by TRPS1::PLAG1 gene fusion.
19. Solid papillary mesothelial tumor
20. An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma
21. Morphologic features in a series of 352 Spitz melanocytic proliferations help predict their oncogenic drivers
22. STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma
23. Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model
24. Clear cell tumor with melanocytic differentiation and MITF-CREM translocation: a novel entity similar to clear cell sarcoma
25. ESR1 Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four Cases
26. Molecular aspects of Ewing's sarcomas
27. Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.
28. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker
29. Recurrent novel THBS1-ADGRF5 gene fusion in a new tumor subtype “Acral FibroChondroMyxoid Tumors”
30. Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center
31. Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations
32. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation
33. Smooth muscle hyperplasia in protein kinase C‐fused blue naevi: Report of 12 cases
34. Uncovering the WWTR1::NCOA2 Gene fusion in low‐grade myoepithelial‐rich neoplasm with HMGA2 expression: A case report
35. Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution
36. CIC-DUX4 sarcomas
37. MST1R/RON fusion as a potential oncogenic driver in Spitz tumours
38. Comprehensive Molecular Characterization of a Large Series of Calcified Chondroid Mesenchymal Neoplasms Widening Their Morphologic Spectrum.
39. MST1R/RONfusion as a potential oncogenic driver in Spitz tumours
40. BAFfling pathologies: Alterations of BAF complexes in cancer
41. Clear Cell Tumor With Melanocytic Differentiation and ACTIN-MITF Translocation: Report of 7 Cases of a Novel Entity
42. SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors
43. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions
44. Translational Aspects of Epithelioid Sarcoma: Current Consensus
45. Supplementary Table S4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
46. FIGURE 4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
47. FIGURE 2 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
48. Supplementary Figure S3 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
49. FIGURE 3 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
50. FIGURE 1 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.